C. Fouchet

Pharmacological characterization of the bradykinin B2 receptor: inter‐species variability and dissociation between binding and functional responses

D. Pruneau, J. Paquet, J. Luccarini, 1999, British journal of pharmacology.

LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor

D. Pruneau, J. Paquet, J. Luccarini, 1998, British journal of pharmacology.

Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140.

M. Amblard, D. Pruneau, J. Paquet, 2009, The journal of peptide research : official journal of the American Peptide Society.

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist.

D. Pruneau, J. Paquet, J. Luccarini, 1999, Immunopharmacology.

In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16‐0335C, on guinea‐pig and rat kinin receptors

D. Pruneau, J. Paquet, J. Luccarini, 1999, Fundamental & clinical pharmacology.

Mechanism of action of progesterone on amphibian oocytes. A possible biological role for progesterone metabolism

R. Bellé, R. Ozon, C. Fouchet, 1975, Molecular and Cellular Endocrinology.

Steroid-protein interactions in bovine plasma.

B. Martin, M. Thibier, C. Fouchet, 1976, Journal of reproduction and fertility.

Mechanism of action of progesterone on amphibian oocytes. Uptake and metabolism of progesterone by isolated oocytes of Pleurodeles waltlii and Xenopus laevis.

R. Bellé, R. Ozon, C. Fouchet, 1975, Comparative biochemistry and physiology. B, Comparative biochemistry.

Transformation of testosterone into 17β-hydroxy-5β-androstan-3-one by Rana esculenta skeletal muscle

R. Ozon, C. Fouchet, F. Perin, 1974 .